Indrayani Biotech

Indrayani Biotech Cash Conversion

The Cash Conversion Rate (OCF/Net Income) of Indrayani Biotech (526445.BO) as of Oct 20, 2026 is 110.39 %. In the previous year, Cash Conversion Rate (OCF/Net Income) was -291.24 % — a change of -137.90% (higher).

Cash Conversion

110.39 %

YoY

-137.90%

Last updated:

Cash Conversion Rate (OCF/Net Income) of Indrayani Biotech is 2025 110.39 % . Cash Conversion Rate (OCF/Net Income) of Indrayani Biotech was 2024 -291.24 % . It decreases by -137.90% higher compared to the previous year.

The Indrayani Biotech Cash Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Cash Conversion
Date
Cash Conversion
Jan 1, 2021
-4.61 INR
Jan 1, 2022
78.07 INR
Jan 1, 2023
135.68 INR
Jan 1, 2024
-291.24 INR
Jan 1, 2025
110.39 INR
The Indrayani Biotech Cash Conversion history
YEARCash ConversionYoY
110.39 %-137.90%
-291.24 %-314.65%
135.68 %+73.79%
78.07 %-1,792.44%
-4.61 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Indrayani Biotech Stock analysis

What does Indrayani Biotech do? Indrayani Biotech Ltd generates revenue through its diverse operational divisions, with the Food & Hospitality division supplying food services on a contract basis to colleges and universities, hospitals and healthcare institutions, corporate offices, industries, and information technology companies. The Engineering division contributes by offering solutions for design, development, manufacture, maintenance, and services in power electronics. The Healthcare division serves patients through single specialty clinics and hospitals, as well as outsourced single specialty departments within multi-specialty hospitals. Additionally, the Infrastructure division engages in real estate and infrastructure development. The Agri division markets and sells products such as organic milk, edible oil, vermi compost, and panchakavya, while the Biotech division focuses on marketing and selling microorganism-based bio fertilizer and bio control. These combined activities allow the Chennai-based company to serve a wide range of clients across engineering, food supply, healthcare, infrastructure, agriculture, and biotechnology sectors. Indrayani Biotech is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Indrayani Biotech stock

Cash Conversion Rate (OCF/Net Income) of Indrayani Biotech is 110.39 % in 2025.

Cash Conversion Rate (OCF/Net Income) of Indrayani Biotech changed from -291.24 % to 110.39 %, representing a -137.90% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Cash Conversion Rate (OCF/Net Income) Indrayani Biotech since 2006 – with annual values, charts, and detailed analysis.

Cash conversion measures how effectively net income converts to operating cash flow. Ratios above 100% indicate high-quality, cash-backed earnings.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Cash Conversion Rate (OCF/Net Income)'s Indrayani Biotech with sector peers and the industry average to assess whether it is attractive.

To evaluate Cash Conversion Rate (OCF/Net Income)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Cash Conversion Rate (OCF/Net Income).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Indrayani Biotech

All Key Metrics — Indrayani Biotech